Frontlight ResearchEarly access
Trial site
The Cancer & Hematology Centers
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Lead sponsor
- Pfizer2 trials
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Metastatic breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026